Proactive Investors - Run By Investors For Investors

The future is about organic growth at Tavistock Investments

Brian Raven, chief executive officer of financial services group Tavistock Investments PLC (LON:TAVI), tells Proactive Investors that not only has the group moved into the black, but all parts of the business are now operating at a profit.

“Three of them [the businesses] were profitable when we acquired them; the other two – the investment management business and the largest transaction that we’ve made, which was that of the financial group – were loss-making, so it’s a big step,” Raven said.

The group as a whole is not only profitable, but cash generative, which is always useful for an investment group.

The group remains extremely picky, however, when it comes to deals, with Raven revealing the group has looked at hundreds (possibly thousands) of potential acquisitions and pulled the trigger on only five.

The key is finding businesses that are run by people that share Tavistock’s values and business philosophy and who want to stay on for at least a couple of years and help build Tavistock, rather than taking the money and running. For now, though, acquiring businesses is likely to take a back seat.

 
Meet Alliance Pharma PLC, IXICO PLC, Benchmark Holdings PLC, Clinigen Group PLC and Shield Therapeutics PLC at our event, London , 24 January 2019. Register here »
View full TAVI profile View Profile

Tavistock Investments Timeline

© Proactive Investors 2019

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use